Literature DB >> 25742445

Threat of interim data leaks prompts call for international rules.

Mollie Bloudoff-Indelicato.   

Abstract

Mesh：

Year:  2015        PMID： 25742445     DOI： 10.1038/nm0315-200

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  3 in total

1.  Commentary: confidentiality of interim trial data-the emerging crisis.

Authors:  Steven E Nissen
Journal:  Clin Trials       Date:  2014-12-18       Impact factor: 2.486

2.  Protecting the confidentiality of interim data: addressing current challenges.

Authors:  Thomas R Fleming
Journal:  Clin Trials       Date:  2014-12-04       Impact factor: 2.486

Review 3.  Interim results in clinical trials: do we need to keep all interim randomised clinical trial results confidential?

Authors:  R J Stephens; R E Langley; P Mulvenna; M Nankivell; A Vail; M K B Parmar
Journal:  Lung Cancer       Date:  2014-05-22       Impact factor: 5.705
  3 in total
  6 in total

1.  Creation of an institutional semi-independent data monitoring committee.

Authors:  Lisa R Tannock; Marietta Barton-Baxter; William W Stoops
Journal:  Clin Trials       Date:  2019-07-01       Impact factor: 2.486

Review 2.  Sharing interim trial results by the Data Safety Monitoring Board with those responsible for the trial's conduct and progress: a narrative review.

Authors:  Victoria Borg Debono; Lawrence Mbuagbaw; Lehana Thabane
Journal:  Trials       Date:  2017-03-09       Impact factor: 2.279

3.  Survey of professional views on sharing interim results by the Data Safety Monitoring Board (DSMB): what to share, with whom and why.

Authors:  Victoria Borg Debono; Lawrence Mbuagbaw; James Paul; Norman Buckley; Lehana Thabane
Journal:  Trials       Date:  2018-05-21       Impact factor: 2.279

4.  Exploring factors associated with views on sharing of certain interim trial result measures by the data safety monitoring board (DSMB) with non-DSMB members.

Authors:  Victoria Borg Debono; Lawrence Mbuagbaw; James Paul; Norman Buckley; Lehana Thabane
Journal:  Trials       Date:  2018-11-12       Impact factor: 2.279

5.  An Analysis of Sponsors/Collaborators of 69,160 Drug Trials Registered with ClinicalTrials.gov.

Authors:  Shruthi Muralidharan Keezhupalat; Ankeet Naik; Saurabh Gupta; Raghunathan Srivatsan; Gayatri Saberwal
Journal:  PLoS One       Date:  2016-02-17       Impact factor: 3.240

6.  Sharing some interim data in trial monitoring can mislead or unmask trial investigators: A scenario-based survey of trial experts.

Authors:  Victoria Borg Debono; Lawrence Mbuagbaw; James Paul; Norm Buckley; Lehana Thabane
Journal:  Contemp Clin Trials Commun       Date:  2017-05-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.